# Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome

> **NCT02717780** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 60 (actual)

## Conditions studied

- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Fentanyl and sevoflurane
- **DRUG:** Remifentanil and desflurane

## Key facts

- **NCT ID:** NCT02717780
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717780, "Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02717780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*